Gwangju, South Korea

Hee Kyoung Kang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Chosun University. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hee Kyoung Kang. Retrieved from https://idiyas.com/inventor/hee-kyoung-kang-g61vimf8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hee Kyoung Kang: Innovator in Antimicrobial Peptides

Introduction

Hee Kyoung Kang is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of antimicrobial peptides, holding a total of 2 patents. His work focuses on developing innovative solutions to combat resistant bacteria.

Latest Patents

Kang's latest patents include an antimicrobial peptide derived from Pseudin-2 peptide and its various applications. This antimicrobial peptide features a specific amino acid sequence, with modifications that enhance its effectiveness. Another patent involves a peptide derived from PEP27 peptide, which is designed to kill or reduce the growth of methicillin-resistant bacteria. This composition can be utilized as an active ingredient in antibiotics, cosmetic compositions, food additives, feed additives, biological pesticides, and quasi-drugs.

Career Highlights

Hee Kyoung Kang is affiliated with the Industry-Academic Cooperation Foundation at Chosun University. His research and innovations have positioned him as a key figure in the development of antimicrobial solutions.

Collaborations

Kang has collaborated with several colleagues, including Yoon Kyung Park and Yoonkyung Park, who contribute to his research endeavors.

Conclusion

Hee Kyoung Kang's work in antimicrobial peptides showcases his commitment to addressing critical health challenges. His innovative patents reflect the potential for significant advancements in medical and agricultural applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…